AMPHASTAR PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$27.72
+2.93%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+9.3%
3 months
+37.1%
6 months
+26.7%
1 year
+12.4%
Year to date
+3.5%
52-week range
$16.87 – $29.40
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.18B
P/E
15
P/B
1.5
P/S
1.6
Revenue
$730.02M
Net income
$78.55M
Diluted EPS
1.69
Gross margin
47.70%
Net margin
10.80%
Return on equity
10.10%
Total debt
$688.32M
Cash
$223.85M
Free cash flow
$152.89M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $183.9M | $30.35M | 50.80% | 16.50% | $42.73M |
| Mar 31, 2026 | $171.17M | $6.42M | 41.10% | 3.80% | $38.33M |
| Dec 31, 2025 | $183.11M | $24.43M | 46.80% | 13.30% | $24.59M |
| Sep 30, 2025 | $191.84M | $17.35M | 51.40% | 9.00% | $47.24M |
| Jun 30, 2025 | $174.41M | $31.03M | 49.60% | 17.80% | $25.03M |
| Mar 31, 2025 | $170.53M | $25.29M | 50.00% | 14.80% | $24.38M |
| Dec 31, 2024 | $186.52M | $37.96M | 46.50% | 20.40% | $16.61M |
| Sep 30, 2024 | $191.21M | $40.43M | 53.30% | 21.10% | $46.17M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent AMPH news
All market newsNo ticker-linked stories are in the current archive.